The CD47 anti-phagocytic ligand is highly expressed in a majority of primary pancreatic cancer stem cells (CSCs) and targeting CD47 on PDAC cells demonstrated changes in the behavior of immunosuppressive resident tumor-associated macrophages (TAMs) to inhibit tumor growth instead [70]. Here, CD47 is linked to neoplasm.